rdca-dap: shortening the timeline for developing new treatments for rare diseases
Published 3 years ago • 325 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
58:44
shortening the timeline for developing new treatments - how the rdca-dap can help
-
31:11
from data to cures: speeding the way for rare diseases
-
3:44
rare disease challenges in each step of the drug development process
-
3:00
how will rdca-dap® support patient-focused drug development?
-
55:49
sharing data with rdca-dap: your questions answered
-
5:36
digital bytes: introducing pure protect™ //draas
-
10:57
1.2 the sendai framework for drr & the sustainable development goals
-
4:28
how much does the health insurance plan cost?
-
1:36
nord timeline | a history of leadership
-
57:50
drug development for rare diseases: a community conversation
-
3:37
what is patient-focused drug development (pfdd)?
-
2:11
research; making a rare impact
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
58:09
patient focused drug development - how rdca-dap can help
-
1:53
nord rare disease day | thank you
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
57:07
what you need to know about the rare disease cures accelerator-data and analytics platform
-
2:30
rare disease registry: using the data
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
7:52
nord , part 1 of 3, health care reform and the rare disease community.